Background Acute decompensated heart failure (ADHF) with reduced ejection fraction often requires inotropic support. While dobutamine is commonly used, its safety and efficacy remain debated.

(UPDATED) A hastily convened collaboration between physicians, pharmacists, and industry experts has pulled together guidance for hospitals and clinicians navigating the US dobutamine shortage that ...

Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the ...

A scarcity of dobutamine is starting to hit home for cardiologists, surgeons, and patients around the United States, catching some hospitals off guard despite warnings for months that supplies were ...

Study Question: What is the effect of a short-term intravenous infusion of levosimendan or dobutamine on long-term survival in acute decompensated heart failure (ADHF)? Methods: The Survival of ...

Patients with cardiogenic shock were assigned to receive milrinone or dobutamine for inotropic support. There was no significant difference between the two groups in the composite primary outcome of ...

Learn everything you need to know about Dobutamine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Dobutamine (Kardia) is a sympathomimetic compound used in the treatment of heart failure and cardiogenic shock. It stimulates the heart muscle. The information provided on this page is intended to ...

Hikma is introducing dobutamine injection, in a 250 mg/20 ml vial. With this launch, Hikma’s growing U.S. portfolio of sterile injectable medicines now exceeds 150 products spanning a wide range of ...